Correx's Proprietary, Aortic Valve Bypass (CAVB®) Kit Enables Off-Pump, Durable Treatment Option for Patients in All Risk Categories of Aortic Stenosis, While Minimizing Risks of Stroke and Pacemaker Requirement 26th Annual European Association for Cardio-Thoracic Surgery (EACTS) Conference WALTHAM, Mass.--(BUSINESS WIRE)--Correx, Inc. today announced that patients requiring treatment of critical aortic stenosis have a new, less invasive option that is gaining worldwide traction. This new treatment will be prominently featured at the 26th Annual European Association for Cardio-Thoracic Surgery (EACTS) Conference in Barcelona, Spain, on Saturday October 27th. Cardiac surgeons Drs. Steffen...
0 Responses to Correx’s Aortic Valve Bypass for Aortic Stenosis to Be Showcased Live at European Association for Cardio-Thoracic Surgery Conference, October 27th